Atossa Therapeutics, Inc. (ATOS)
2.63
-0.02
(-0.75%)
USD |
NASDAQ |
Aug 27, 16:00
2.63
0.00 (0.00%)
After-Hours: 20:00
Atossa Therapeutics Total Liabilities (Quarterly) : 5.451M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.451M |
| March 31, 2026 | 7.457M |
| December 31, 2025 | 8.255M |
| September 30, 2025 | 8.225M |
| June 30, 2025 | 6.82M |
| March 31, 2025 | 5.425M |
| December 31, 2024 | 4.967M |
| September 30, 2024 | 5.796M |
| June 30, 2024 | 5.696M |
| March 31, 2024 | 5.328M |
| December 31, 2023 | 5.236M |
| September 30, 2023 | 3.444M |
| June 30, 2023 | 3.478M |
| March 31, 2023 | 2.944M |
| December 31, 2022 | 5.569M |
| September 30, 2022 | 2.868M |
| June 30, 2022 | 3.792M |
| March 31, 2022 | 2.322M |
| December 31, 2021 | 3.127M |
| September 30, 2021 | 1.676M |
| June 30, 2021 | 1.796M |
| March 31, 2021 | 1.379M |
| December 31, 2020 | 15.68M |
| September 30, 2020 | 1.567M |
| June 30, 2020 | 1.831M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.916M |
| December 31, 2019 | 1.345M |
| September 30, 2019 | 1.578M |
| June 30, 2019 | 1.057M |
| March 31, 2019 | 1.528M |
| December 31, 2018 | 2.915M |
| September 30, 2018 | 3.555M |
| June 30, 2018 | 3.011M |
| March 31, 2018 | 0.7207M |
| December 31, 2017 | 1.225M |
| September 30, 2017 | 1.072M |
| June 30, 2017 | 1.906M |
| March 31, 2017 | 0.7748M |
| December 31, 2016 | 1.047M |
| September 30, 2016 | 0.8638M |
| June 30, 2016 | 0.8743M |
| March 31, 2016 | 1.327M |
| December 31, 2015 | |
| September 30, 2015 | 3.298M |
| June 30, 2015 | 3.436M |
| March 31, 2015 | 3.519M |
| December 31, 2014 | 2.266M |
| September 30, 2014 | 1.540M |
| June 30, 2014 | 1.564M |
| March 31, 2014 | 1.082M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Immix Biopharma, Inc. | 10.19M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.28M |
| Shareholders Equity (Quarterly) | 26.83M |
| Current Ratio | 5.689 |